Ticker League

Operating Cash Flow for Bristol-Myers Squibb (BMY)

As of · Reported

Metric

Latest period

$1.10B

YoY change

-6.8%

5Y CAGR

+0.1%

Peak year (2021)

$16.21B

Operating Cash Flow history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025

Latest: $14.16B

Operating Cash Flow growth chart for Bristol-Myers Squibb (BMY) from 1989 to 2025

Latest: -6.8%

Operating Cash Flow history table for Bristol-Myers Squibb (BMY) from 1989 to 2025

  • 2025$14.16B-6.8%
  • 2024$15.19B+9.6%
  • 2023$13.86B+6.1%
  • 2022$13.07B-19.4%
  • 2021$16.21B+15.3%
  • 2020$14.05B+71.2%
  • 2019$8.21B+16.2%
  • 2018$7.07B+34.0%
  • 2017$5.28B+72.5%
  • 2016$3.06B+45.3%
  • 2015$2.10B-33.1%
  • 2014$3.15B-11.2%
  • 2013$3.54B-48.9%
  • 2012$6.94B+43.4%
  • 2011$4.84B+7.8%
  • 2010$4.49B+10.5%
  • 2009$4.07B+9.7%
  • 2008$3.71B+17.6%
  • 2007$3.15B+51.4%
  • 2006$2.08B+13.5%
  • 2005$1.84B-42.2%
  • 2004$3.18B-9.6%
  • 2003$3.51B+271.6%
  • 2002$945.00M-82.5%
  • 2001$5.40B+16.1%
  • 2000$4.65B+10.1%
  • 1999$4.22B+11.7%
  • 1998$3.78B+52.7%
  • 1997$2.48B-6.2%
  • 1996$2.64B+5.7%
  • 1995$2.50B+8.6%
  • 1994$2.30B-10.8%
  • 1993$2.58B+27.2%
  • 1992$2.03B+10.5%
  • 1991$1.83B+4.7%
  • 1990$1.75B+47.2%
  • 1989$1.19B—

Operating Cash Flow values are taken from Bristol-Myers Squibb's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Bristol-Myers Squibb (BMY)

Operating Cash Flow for Bristol-Myers Squibb (BMY): headline value $1.10B · YoY -6.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Bristol-Myers Squibb (BMY) operating cash flow is $14.16B – declined 6.8% year-over-year.

Through 2020–2025 (5 years), Bristol-Myers Squibb operating cash flow delivered a +0.1% annualised rate; with mixed annual results across the window.

Bristol-Myers Squibb operating cash flow peaked at $16.21B in 2021; the latest annual figure is $14.16B in 2025 (12.7% below peak).

$16.21B stands as the all-time-high annual operating cash flow, posted in 2021, against a low of $945.00M during 2002.

Bristol-Myers Squibb Operating Cash Flow by Year

Bristol-Myers Squibb Operating Cash Flow 2025: $14.16B

2025's operating cash flow for Bristol-Myers Squibb came in at $14.16B, declined 6.8% below 2024.

Bristol-Myers Squibb Operating Cash Flow 2024: $15.19B

Bristol-Myers Squibb posted operating cash flow of $15.19B in 2024, grew 9.6% from 2023.

Bristol-Myers Squibb Operating Cash Flow 2023: $13.86B

In 2023, Bristol-Myers Squibb reported operating cash flow of $13.86B, grew 6.1% from 2022.

Bristol-Myers Squibb Operating Cash Flow 2022: $13.07B

Bristol-Myers Squibb operating cash flow in 2022 was $13.07B, declined 19.4% below 2021.

Bristol-Myers Squibb Operating Cash Flow 2021: $16.21B

Bristol-Myers Squibb operating cash flow in 2021 was $16.21B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Operating Cash Flow

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest operating cash flow

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview